Reneo Pharmaceuticals

Reneo Pharmaceuticals

  • Founded: 2018
  • Location: Irvine, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin2/Clin3
  • Therapy area: Mitochondrial myopathies
  • Drug types: GEN, MUS, RAR
  • Lead product: REN001
  • Product link:
  • Funding: $55M stock May 2023; $93.8M IPO Apr 2021; $95M B Dec 2020; $50M May 2019; $50M total Dec 2018
  • Investors: Lundbeckfonden, NEA, Pappas Capital, RiverVest

job board

Short description:

Genetically-Defined Orphan Therapies

Drug notes:

Also additional Clin2 mitochondrial myopathies, Clin2 fatty acid oxidation disorders (ODD)

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy